151 related articles for article (PubMed ID: 20224366)
1. Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
Rourke LL; Hunt KK
Ann Surg; 2010 Apr; 251(4):592-4. PubMed ID: 20224366
[No Abstract] [Full Text] [Related]
2. Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
Fujita T
Ann Surg; 2011 Jun; 253(6):1233; author reply 1233-4. PubMed ID: 21522008
[No Abstract] [Full Text] [Related]
3. Survival benefit of breast-conserving surgery with adjuvant radiotherapy for young women with ductal carcinoma in situ: A population-based cohort study.
Tang J; Wang J; Zhang D; Pan X
Asian J Surg; 2023 Aug; 46(8):3173-3175. PubMed ID: 36898916
[No Abstract] [Full Text] [Related]
4. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
Buchholz TA; Haffty BG; Harris JR
J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
[No Abstract] [Full Text] [Related]
5. Radiation Therapy Following Breast Conserving Surgery for Ductal Carcinoma in situ: Yes or No?
Stoleru LS; Stoleru S
Chirurgia (Bucur); 2017; 112(4):403-412. PubMed ID: 28862116
[TBL] [Abstract][Full Text] [Related]
6. [Small DCIS: In favour of postoperative radiotherapy].
Cutuli B
Gynecol Obstet Fertil; 2012 Jun; 40(6):384-6. PubMed ID: 22658906
[No Abstract] [Full Text] [Related]
7. Radiation therapy after breast conserving surgery increases long-term breast conservation for DCIS patients.
Kaidar-Person O; Meattini I; Poortmans P
Breast; 2018 Feb; 37():179-180. PubMed ID: 29100639
[No Abstract] [Full Text] [Related]
8. Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.
Shah C; Vicini F
Ann Surg Oncol; 2023 Oct; 30(11):6281-6283. PubMed ID: 37280311
[No Abstract] [Full Text] [Related]
9. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
Fisher ER
CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
Dick AW; Sorbero MS; Ahrendt GM; Hayman JA; Gold HT; Schiffhauer L; Stark A; Griggs JJ
J Natl Cancer Inst; 2011 Jan; 103(2):92-104. PubMed ID: 21200025
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy of breast carcinoma. 2005 version].
Organgruppe "Mammakarzinom" der DEGRO
Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
[No Abstract] [Full Text] [Related]
12. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Mulliez T; De Ridder M
Lancet; 2023 Jan; 401(10370):23-24. PubMed ID: 36610767
[No Abstract] [Full Text] [Related]
13. Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
Cho WK; Choi DH; Park W; Kim H; Cha H
Breast; 2019 Oct; 47():16-21. PubMed ID: 31265973
[TBL] [Abstract][Full Text] [Related]
14. Breast radiotherapy for ductal carcinoma in situ: could less be more?
Coles CE; Chatterjee S; Jagsi R; Kirby AM
Lancet; 2022 Aug; 400(10350):408-410. PubMed ID: 35933995
[No Abstract] [Full Text] [Related]
15. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
Chua BH; Link EK; Kunkler IH; Olivotto IA
Lancet; 2023 Jan; 401(10370):24. PubMed ID: 36610769
[No Abstract] [Full Text] [Related]
16. Random physician effect and comparative effectiveness of treatment for ductal carcinoma in situ.
Virnig BA; Tuttle TM
J Natl Cancer Inst; 2011 Jan; 103(2):81-2. PubMed ID: 21200026
[No Abstract] [Full Text] [Related]
17. The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy.
Park S; Park HS; Kim SI; Koo JS; Park BW; Lee KS
Jpn J Clin Oncol; 2011 May; 41(5):600-8. PubMed ID: 21355001
[TBL] [Abstract][Full Text] [Related]
18. Part V. Adjuvant therapies for ductal carcinoma in situ.
Kim JJ
Curr Probl Cancer; 2000; 24(3):163-74. PubMed ID: 10919317
[No Abstract] [Full Text] [Related]
19. Evolution of breast-conserving therapy for localized breast cancer.
Schnitt SJ; Harris JR
J Clin Oncol; 2008 Mar; 26(9):1395-6. PubMed ID: 18349387
[No Abstract] [Full Text] [Related]
20. Part IV. Surgery for ductal carcinoma in situ.
Holloway C
Curr Probl Cancer; 2000; 24(3):141-62. PubMed ID: 10919316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
